ID: MRFR/HC/6095-CR | 110 Pages | Published By Kinjoll Dey on March 2019
The chlorhexidine gluconate (CHG) wipes market is expected to grow a CAGR of 4.78% to reach USD 13948.89 thousand till 2030
Chlorhexidine Gluconate (CHG) Wipes Market Overview:
The chlorhexidine gluconate (CHG) wipes market is expected to register a CAGR of 4.78% to reach USD 13948.89 thousand till 2030. CHG wipes are antiseptic wipes that contain Chlorhexidine Gluconate (CHG). These wipes are permeated with CHG which helps to kill bacteria and prevent wound infection.
The rising number of hospital-acquired infection (HAI) cases, an increasing number of surgical procedures & surgical site infections and growing geriatric population have led to the growth of the global CHG wipes market in the recent years. However, side-effects of CHG and product recalls are likely to restrain market growth over the forecast period.
The World Health Organization (WHO) stated that millions of patients are affected by healthcare-associated infections worldwide each year, leading to significant mortality and financial losses. According to a report published by the European Centre for Disease Prevention and Control in June 2017, approximately 30% of the patients in ICUs are affected by at least one episode of healthcare-associated infection. This huge population affected with healthcare-acquired infections is increasing the demand for CHG Wipes and contributing to boost the growth of CHG wipes market.
The global CHG wipes market, by product type, has been segmented into CHG bath wipes and CHG/alcohol-based wipes. The market, by CHG concentration, can be segmented into 2% and 0.5%. On the basis of application, the global CHG wipes market is segmented into surgical site infection, central line-associated bloodstream infection, catheter-associated urinary tract infections, and lens cleaners. The CHG wipes market on the basis of distribution channel, is segmented into hospitals & retail pharmacies and online platforms. The hospital and retail pharmacies segment accounted for a value of USD 6,407.63 in 2017.
The global CHG Wipes market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to dominate the global CHG Wipes market. This is owing to the increasing prevalence of patients suffering from chronic illness with rising hospital admissions for surgical procedures. Also, high healthcare spending, well-developed technology, and increasing geriatric population are some factors that are expected to drive the market growth in the region.
Europe showed a considerable amount of growth in the market due to high healthcare spending. Asia-Pacific is estimated to be the fastest growing region in the global market. Enormous opportunities for the development of CHG wipes and the presence of a huge patient population are likely to be the key factors for the growth of the Asia-Pacific CHG wipes market during the forecast period. Australia held a share of 10.7% in the Asia-Pacific CHG Wipes market in 2017. On the other hand, the Middle East and Africa has the least share of the market due to the limited availability of funds and medical facilities.
The prominent players in the global CHG wipes market are Becton, Dickinson and Company (US), 3M (US), Cardinal Health (US), GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK) and others.
Some of the key strategies followed by players operating in the chlorhexidine gluconate (CHG) wipes market were innovation, product development, acquisition, and expansion.
Chlorhexidine gluconate (CHG) wipes market, by Product Type
Chlorhexidine gluconate (CHG) wipes market, by Concentration
Chlorhexidine gluconate (CHG) wipes market, by Application
Chlorhexidine gluconate (CHG) wipes market, by Distribution Channel
Chlorhexidine gluconate (CHG) wipes market, by Region
Available Additional Customizations
|Market Size||USD 13.95 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||By Product Type, Concentration, Application, Distribution Channel, and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Becton, Dickinson and Company (US), 3M (US), Cardinal Health (US), GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK) and others.|
|Key Market Opportunities||Development of CHG wipes and the presence of a huge patient population and Investment by industry players|
|Key Market Drivers||Increasing prevalence of surgical site infections.|
The market is majorly driven by the increasing prevalence of surgical site infections.
The side effects of CHG are the main restraint on the global market.
The Americas hold the dominant share in the global market, due to the widespread adoption of CHG wipes in the healthcare sector in the region.
Leading players in the CHG wipes market include Becton Dickinson and Company, 3M, Cardinal Health, Carenow Medical, GAMA Healthcare Ltd., Lernapharm Inc., and PDI Limited, among others.
The CHG wipes market is expected to exhibit a solid 4.78% CAGR over the forecast period from 2020 to 2030.